{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:31:07Z","timestamp":1792791067789,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Institute for Convergence of biomedical science and technology, Pusan National University Yangsan Hospital","award":["30-2024-016"],"award-info":[{"award-number":["30-2024-016"]}],"id":[{"id":"https:\/\/ror.org\/04kgg1090","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36860-0","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:05:24Z","timestamp":1769267124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of cytotoxicity, wound healing, and anti-inflammatory effects of netarsudil on human corneal epithelial cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Kwang Eon","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hyo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangwoo","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ye","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"36860_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham, Y. C. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121, 2081\u20132090 (2014).","journal-title":"Ophthalmology"},{"key":"36860_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","volume":"17","author":"EW Leung","year":"2008","unstructured":"Leung, E. W., Medeiros, F. A. & Weinreb, R. N. Prevalence of ocular surface disease in glaucoma patients. J. Glaucoma. 17, 350\u2013355 (2008).","journal-title":"J. Glaucoma"},{"key":"36860_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","volume":"153","author":"SE Skalicky","year":"2012","unstructured":"Skalicky, S. E., Goldberg, I. & McCluskey, P. Ocular surface disease and quality of life in patients with glaucoma. Am. J. Ophthalmol. 153, 1\u20139 (2012).","journal-title":"Am. J. Ophthalmol."},{"key":"36860_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/bjo.86.4.418","volume":"86","author":"PJ Pisella","year":"2002","unstructured":"Pisella, P. J., Pouliquen, P. & Baudouin, C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br. J. Ophthalmol. 86, 418\u2013423 (2002).","journal-title":"Br. J. Ophthalmol."},{"key":"36860_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/112067210701700311","volume":"17","author":"N Jaenen","year":"2007","unstructured":"Jaenen, N. et al. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur. J. Ophthalmol. 17, 341\u2013349 (2007).","journal-title":"Eur. J. Ophthalmol."},{"key":"36860_CR6","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.1167\/iovs.16-20189","volume":"57","author":"R Ren","year":"2016","unstructured":"Ren, R. et al. Netarsudil increases outflow facility in human eyes through multiple mechanisms. Invest. Ophthalmol. Vis. Sci. 57, 6197\u20136209 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"36860_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajo.2017.11.019","volume":"186","author":"JB Serle","year":"2018","unstructured":"Serle, J. B. et al. Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2). Am. J. Ophthalmol. 186, 116\u2013127 (2018).","journal-title":"Am. J. Ophthalmol."},{"key":"36860_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cm.20472","volume":"67","author":"M Amano","year":"2010","unstructured":"Amano, M., Nakayama, M. & Kaibuchi, K. Rho-kinase\/ROCK: A key regulator of the cytoskeleton and cell Polarity. Cytoskeleton (Hoboken). 67, 545\u2013554 (2010).","journal-title":"Cytoskeleton (Hoboken)"},{"key":"36860_CR9","doi-asserted-by":"publisher","first-page":"C378","DOI":"10.1152\/ajpcell.90624.2007","volume":"295","author":"J Yin","year":"2008","unstructured":"Yin, J. & Yu, F. S. Rho kinases regulate corneal epithelial wound healing. Am. J. Physiol. Cell. Physiol. 295, C378\u2013387 (2008).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"36860_CR10","doi-asserted-by":"publisher","first-page":"101287","DOI":"10.1016\/j.ajoc.2022.101287","volume":"25","author":"JA Tran","year":"2022","unstructured":"Tran, J. A., Jurkunas, U. & Lin, M. M. Netarsudil-associated reticular corneal epithelial edema. Am. J. Ophthalmol. Case Rep. 25, 101287 (2022).","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"36860_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1167\/iovs.17-22679","volume":"58","author":"T Uchida","year":"2017","unstructured":"Uchida, T. et al. The Anti-Inflammatory effect of Ripasudil (K-115), a Rho kinase (ROCK) Inhibitor, on Endotoxin-Induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 58, 755\u2013763 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"36860_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/cells14040258","volume":"14","author":"U Schlotzer-Schrehardt","year":"2025","unstructured":"Schlotzer-Schrehardt, U. et al. Drug- and Cell-Type-Specific effects of ROCK inhibitors as a potential cause of reticular corneal epithelial edema. Cells 14, 258 (2025).","journal-title":"Cells"},{"key":"36860_CR13","doi-asserted-by":"publisher","first-page":"110351","DOI":"10.1016\/j.exer.2025.110351","volume":"255","author":"S Tazoe","year":"2025","unstructured":"Tazoe, S. et al. Ripasudil does not induce phospholipid accumulation in human corneal epithelial cells. Exp. Eye Res. 255, 110351 (2025).","journal-title":"Exp. Eye Res."},{"key":"36860_CR14","first-page":"614","volume":"36","author":"K Araki-Sasaki","year":"1995","unstructured":"Araki-Sasaki, K. et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest. Ophthalmol. Vis. Sci. 36, 614\u2013621 (1995).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"36860_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","volume":"15","author":"MD Willcox","year":"2017","unstructured":"Willcox, M. D. et al. TFOS DEWS II tear film report. Ocul Surf. 15, 366\u2013403 (2017).","journal-title":"Ocul Surf."},{"key":"36860_CR16","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.3390\/ijms24032758","volume":"24","author":"J Weng","year":"2023","unstructured":"Weng, J., Fink, M. K. & Sharma, A. A. Critical appraisal of the physicochemical properties and biological effects of artificial tear ingredients and formulations. Int. J. Mol. Sci. 24, 2758 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"36860_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65, 55\u201363 (1983).","journal-title":"J. Immunol. Methods"},{"key":"36860_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","volume":"115","author":"T Decker","year":"1988","unstructured":"Decker, T. & Lohmann-Matthes, M. L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods. 115, 61\u201369 (1988).","journal-title":"J. Immunol. Methods"},{"key":"36860_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10856-024-06800-3","volume":"35","author":"AM Margot","year":"2024","unstructured":"Margot, A. M. et al. Quantitatively measuring the cytotoxicity of viscous hydrogels with direct cell sampling in a micro scale format microdrop and its comparison to CCK8. J. Mater. Sci. Mater. Med. 35, 34 (2024).","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"36860_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1083\/jcb.17.1.208","volume":"17","author":"ES Reynolds","year":"1963","unstructured":"Reynolds, E. S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell. Biol. 17, 208\u2013212 (1963).","journal-title":"J. Cell. Biol."},{"key":"36860_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"CC Liang","year":"2007","unstructured":"Liang, C. C., Park, A. Y. & Guan, J. L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2, 329\u2013333 (2007).","journal-title":"Nat. Protoc."},{"key":"36860_CR22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bjo.2009.168229","volume":"94","author":"C Baudouin","year":"2010","unstructured":"Baudouin, C. et al. Preservatives in glaucoma medication: an overview. Br. J. Ophthalmol. 94, 1111\u20131115 (2010).","journal-title":"Br. J. Ophthalmol."},{"key":"36860_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/archopht.1981.03930010303017","volume":"99","author":"MB Abelson","year":"1981","unstructured":"Abelson, M. B., Udell, I. J. & Weston, J. H. Normal human tear pH by direct measurement. Arch. Ophthalmol. 99, 301 (1981).","journal-title":"Arch. Ophthalmol."},{"key":"36860_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig, J. P. et al. TFOS DEWS II definition and classification report. Ocul Surf. 15, 276\u2013283 (2017).","journal-title":"Ocul Surf."},{"key":"36860_CR25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron, A. J. et al. TFOS DEWS II pathophysiology report. Ocul Surf. 15, 438\u2013510 (2017).","journal-title":"Ocul Surf."},{"key":"36860_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0092-8674(95)90370-4","volume":"81","author":"CD Nobes","year":"1995","unstructured":"Nobes, C. D. & Hall, A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53\u201362 (1995).","journal-title":"Cell"},{"key":"36860_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/FJC.0b013e3182a3718f","volume":"62","author":"J Shi","year":"2013","unstructured":"Shi, J. & Wei, L. Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil. J. Cardiovasc. Pharmacol. 62, 341\u2013354 (2013).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"36860_CR28","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1167\/iovs.08-2634","volume":"50","author":"N Okumura","year":"2009","unstructured":"Okumura, N. et al. Enhancement on primate corneal endothelial cell survival in vitro and in vivo by Rho kinase inhibitors. Invest. Ophthalmol. Vis. Sci. 50, 3680\u20133687 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"36860_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ajo.2020.04.002","volume":"217","author":"CE Wisely","year":"2020","unstructured":"Wisely, C. E. et al. Reticular corneal epithelial edema associated with netarsudil use. Am. J. Ophthalmol. 217, 20\u201326 (2020).","journal-title":"Am. J. Ophthalmol."},{"key":"36860_CR30","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.ophtha.2018.08.004","volume":"125","author":"A Fernandez","year":"2018","unstructured":"Fernandez, A. et al. Reticular corneal epithelial edema associated with netarsudil use. Ophthalmology 125, 1709\u20131712 (2018).","journal-title":"Ophthalmology"},{"key":"36860_CR31","doi-asserted-by":"publisher","first-page":"e0144571","DOI":"10.1371\/journal.pone.0144571","volume":"10","author":"CC Sun","year":"2015","unstructured":"Sun, C. C. et al. Y-27632, a ROCK Inhibitor, promoted limbal epithelial cell proliferation and corneal wound healing. PLoS One. 10, e0144571 (2015).","journal-title":"PLoS One"},{"key":"36860_CR32","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1242\/jcs.114.15.2713","volume":"114","author":"AJ Ridley","year":"2001","unstructured":"Ridley, A. J. Rho GTPases and cell migration. J. Cell. Sci. 114, 2713\u20132722 (2001).","journal-title":"J. Cell. Sci."},{"key":"36860_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1542-0124(12)70279-3","volume":"6","author":"E Pearlman","year":"2008","unstructured":"Pearlman, E. et al. Toll-like receptors at the ocular surface. Ocul Surf. 6, 108\u2013116 (2008).","journal-title":"Ocul Surf."},{"key":"36860_CR34","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1167\/iovs.13-13842","volume":"55","author":"K Yamamoto","year":"2014","unstructured":"Yamamoto, K. et al. The novel Rho kinase (ROCK) inhibitor K-115: A new candidate drug for neuroprotective treatment in glaucoma. Invest. Ophthalmol. Vis. Sci. 55, 7126\u20137136 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"36860_CR35","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S0016-5085(03)00283-X","volume":"124","author":"JP Segain","year":"2003","unstructured":"Segain, J. P. et al. Rho kinase Blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in crohn\u2019s disease and experimental colitis. Gastroenterology 124, 1180\u20131187 (2003).","journal-title":"Gastroenterology"},{"key":"36860_CR36","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.12659\/MSM.907277","volume":"24","author":"J Gong","year":"2018","unstructured":"Gong, J., Guan, L., Tian, P., Li, C. & Zhang, Y. Rho kinase type 1 (ROCK1) promotes Lipopolysaccharide-induced inflammation in corneal epithelial cells by activating Toll-Like receptor 4 (TLR4)-Mediated signaling. Med. Sci. Monit. 24, 3722\u20133730 (2018).","journal-title":"Med. Sci. Monit."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36860-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36860-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36860-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:28:56Z","timestamp":1781080136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36860-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36860"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36860-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: The Funding section in the original version of this Article has been removed.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6164"}}